#220 ‒ Ketamine: Benefits, risks, and promising therapeutic potential | Celia Morgan, Ph.D.

Aug 29, 2022 Episode Page ↗
Overview

Celia Morgan, Professor of Psychopharmacology at the University of Exeter, delves into ketamine's neurobiology, its therapeutic promise for recalcitrant depression and alcohol addiction, and how it differs from other psychedelics. She emphasizes the critical role of psychotherapy in maximizing ketamine's benefits and discusses potential risks and safe usage.

At a Glance
14 Insights
1h 27m Duration
14 Topics
8 Concepts

Deep Dive Analysis

Celia Morgan's Background and Early Ketamine Research

History of Ketamine: Anesthetic Use and PCP Comparison

Neurobiology of Ketamine: Glutamate, GABA, and NMDA Receptors

Ketamine's Dose-Dependent Effects and Recreational Use Risks

Ketamine Regulation and Abuse Potential Compared to Other Drugs

Distinguishing Ketamine from Classical Psychedelics (LSD, Psilocybin)

Ketamine's Emergence as a Treatment for Depression

Acute Effects of Ketamine Infusion and Response Variability

Duration of Ketamine's Antidepressant Effects and Neuroplasticity

Concerns with Long-Term or Daily Ketamine Dosing

Ketamine as a Treatment for Alcohol Addiction: Historical Context

Celia Morgan's Clinical Trial on Ketamine and Therapy for Alcoholism

Insights from the Alcohol Addiction Trial's Control Groups

Advice for Navigating Ketamine Clinics and Safe Use

NMDA Receptor

A crucial receptor in the brain where glutamate, the major excitatory neurotransmitter, acts. It's fundamental for higher cognitive functions like learning and memory, and ketamine primarily exerts its effects by blocking this receptor.

Glutamate

The brain's primary excitatory neurotransmitter, found throughout the brain, essential for processes like long-term potentiation, which is the basis of learning and memory. Ketamine's action on NMDA receptors influences glutamate flow.

GABA

An inhibitory neurotransmitter in the brain that works to slow down or shut off electrical impulses. Drugs like alcohol and benzodiazepines increase GABA activation, leading to relaxing or sedating effects.

Dissociative Anesthetics

A class of drugs including ketamine, PCP, and nitrous oxide, named for their ability to dissociate individuals from their body and induce out-of-body experiences. This property is what limited ketamine's routine clinical use initially.

Tachyphylaxis

A rapid decrease in response to a drug after repeated administration, requiring increasingly higher doses to achieve the same effect. This phenomenon is observed with ketamine, especially in recreational users taking high doses frequently.

Treatment-Resistant Depression

A classification for depression where a patient has not responded to at least two conventional antidepressant treatments during their current depressive episode. Ketamine has shown promise in providing rapid relief for this severe form of depression.

Synaptic Plasticity

The brain's capacity to change and adapt by forming new connections between neurons, including the growth of new synapses and dendrites. Ketamine is thought to increase this plasticity, which correlates with its antidepressant effects and the brain's ability to learn new things.

Default Mode Network (DMN)

A network of brain regions active during resting states or when the mind is not focused on a specific task, often associated with self-referential thought, rumination, and mind-wandering. Psychedelics like ketamine are shown to disrupt this network.

?
What is ketamine and how was it initially used?

Ketamine was synthesized in the 1960s as an anesthetic, intended as a safer replacement for PCP, and is still widely used in medicine today due to its physiological safety profile, especially in trauma settings.

?
How does ketamine work in the brain?

Ketamine primarily works by blocking NMDA receptors on glutamatergic neurons and GABAergic interneurons, leading to a net effect of increasing glutamate flow and triggering a downstream cascade that enhances synaptic plasticity.

?
What are the different effects of ketamine at various doses?

At low doses, ketamine can have stimulant properties; at increasing doses, it causes perceptual distortions, floating sensations, profound hallucinations, and at the highest doses, a catatonic, anesthetized state where individuals are completely dissociated from reality.

?
How does ketamine's abuse potential compare to other drugs?

While 9% of recreational ketamine users in one study showed signs of dependence, it's difficult to benchmark against opioids or benzodiazepines directly; however, repeated high doses can lead to severe physiological consequences like bladder toxicity.

?
How does ketamine differ from classical psychedelics like LSD and psilocybin?

Ketamine works on glutamatergic NMDA receptors, unlike LSD and psilocybin which act on 5-HT2A receptors; ketamine causes profound ego dissolution and anxiolytic effects, often without the intense anxiety that can accompany classical psychedelics.

?
How quickly does ketamine work for treatment-resistant depression, and how long do the effects typically last?

Ketamine can produce a rapid reduction in depressive symptoms, often immediately after infusion, with effects typically lasting from two days to a week, though some individuals experience longer relief.

?
What fraction of patients with treatment-resistant depression respond to ketamine?

Early studies showed response rates as high as 75%, but with more data, the response rate for ketamine in treatment-resistant depression is estimated to be around 50-60%.

?
What is the role of psychotherapy in ketamine treatment for mental health conditions?

Combining ketamine with psychological therapy, especially when the brain is most plastic after ketamine administration, appears to significantly extend the antidepressant response and enhance outcomes in conditions like alcohol addiction.

?
What are the risks of long-term or high-dose recreational ketamine use?

Chronic, high-dose recreational ketamine use can lead to severe physiological problems like direct toxicity to the bladder lining (requiring cystectomy in extreme cases) and cognitive impairments, including reductions in planning ability and hippocampal function.

?
How effective is ketamine combined with therapy for alcohol addiction?

A clinical trial found that ketamine combined with psychotherapy resulted in 86% abstinence rates at six months for individuals with alcohol problems, significantly outperforming control groups.

?
What should people consider before seeking ketamine therapy at a clinic?

It is advisable to seek ketamine treatment embedded within a therapeutic framework, as evidence suggests therapy enhances and extends the benefits; patients should also be wary of unsupervised use or models that promote continuous, high-frequency dosing.

1. Avoid Unsupervised Ketamine Use

Never take ketamine at home unsupervised, especially at high doses, due to the risk of complete dissociation from your environment, making you vulnerable to accidents like drowning or inability to respond to emergencies.

2. Combine Ketamine with Therapy

To maximize and extend the antidepressant effects of ketamine, ensure it is administered alongside psychological therapy, as this approach has shown to significantly prolong the positive response.

3. Target Therapy to Neuroplasticity Window

Schedule psychological therapy sessions approximately 24 hours after ketamine administration, as this period is when the brain is most plastic and able to form new connections, optimizing the learning of new thought patterns.

4. Avoid Daily Heavy Ketamine Dosing

Refrain from daily heavy doses of ketamine, even if low, as this can lead to dose escalation, cognitive impairments, reduced hippocampal function, and a general ‘dullness’ or loss of life’s ‘spark’.

5. Be Aware of Bladder Toxicity

Understand that repeated high-dose ketamine use can cause direct toxicity to the bladder lining, potentially leading to severe physiological problems like the need for a cystectomy.

6. Ketamine for Alcohol Addiction Protocol

For alcohol use disorder, consider a protocol involving three ketamine infusions (0.8 mg/kg, 7-14 days apart) combined with 11 hours of manualized psychological therapy, as this demonstrated significant abstinence rates at six months.

7. Alcohol Addiction Therapy Focus

In therapy for alcohol addiction, focus on identifying risky situations, preempting relapse, envisioning a life without alcohol, challenging thinking biases, planning, journaling, and using mindfulness techniques to manage cravings.

8. Question Frequent Ketamine Dosing

If considering ketamine treatment, question the necessity of frequent, long-term dosing (e.g., twice-weekly for life), as this model can be disempowering for patients and may not be necessary for sustained benefit.

9. Recreational Ketamine Harm Reduction

If using ketamine recreationally, always start with a very small dose, use it in a safe place, and ensure a sober person is supervising, as the drug can be cut with other substances and cause complete dissociation.

10. Recognize Non-Pharmacological Addiction Factors

Understand that strong intention, overcoming treatment hurdles, consistent monitoring (e.g., ankle tags), and social support/human kindness can significantly contribute to abstinence in alcohol addiction, even without active drug or intensive therapy.

11. Avoid Psychotherapy During Ketamine Influence

Do not engage in intensive psychotherapy during the acute influence of ketamine, as patients are too dissociated and their memory is impaired; focus on support during this phase and therapy afterwards.

12. Consider Additional Ketamine Doses

If initial ketamine infusions (e.g., three doses) for depression do not yield a response, consider additional doses, as some evidence suggests a fourth dose might increase the response.

13. Understand Ketamine Dose Effects

Be aware that ketamine’s effects vary significantly by dose, ranging from mild stimulant properties at low doses to profound dissociation and hallucinations at higher doses.

14. Explore Podcast Membership Benefits

If you want to deepen your knowledge of health and wellness, consider subscribing to the podcast’s membership program for more in-depth, exclusive content.

If you're looking for kind of escapism, you don't want to escape into absolute terror.

Peter Attia

neurons that fire together, wire together.

Celia Morgan

You are completely dissociated. And it's really sad. It was someone that I was working with, and it's not the only example I know of people who that's happened to, various different accidents. It's really tragic.

Celia Morgan

The film Awakenings, which is actually about Parkinson's. These people are really severely depressed. They often can't get out of bed and that they suddenly come alive.

Celia Morgan

I think the idea, you know, for me as a psychologist is that you could time your psychological therapy when your brain is most plastic and most able to learn new things.

Celia Morgan

I don't think people want to be kind of stuck on a drug, even if you're not addicted, but you're going in twice a week, or even once a week. That's so disempowering for patients.

Celia Morgan

Ketamine-Assisted Therapy for Alcohol Addiction (Celia Morgan's Trial)

Celia Morgan
  1. Achieve abstinence from alcohol, often requiring medical detox, before starting treatment.
  2. Undergo a pre-screening process to check for medical and psychiatric contraindications, such as psychosis or uncontrolled blood pressure.
  3. Receive a therapy session (e.g., mindfulness practice) immediately before the ketamine infusion.
  4. Receive a ketamine infusion (0.8 mg/kg intramuscularly).
  5. Recover from the acute effects of the infusion.
  6. Attend a longer (90-minute) therapy session the following day, timed to coincide with peak synaptic plasticity.
  7. Repeat steps 3-6 for a total of three ketamine infusions, typically spaced one to two weeks apart, for a total of seven therapy sessions.
10 times less potent
Ketamine potency compared to PCP Refers to its action on the NMDA receptor
1996
Ketamine scheduling in US Became a Schedule III controlled substance
9%
Recreational ketamine user dependence Observed in a study of non-medical ketamine users
2000
First major study on ketamine for depression Conducted by Robert Berman at Yale, showing rapid antidepressant effects
0.5 milligrams per kilogram
Ketamine dose for depression (initial studies) Administered intravenously over 40 minutes for treatment-resistant depression
100-200 milligrams
Typical recreational ketamine dose Often taken intramuscularly or intranasally, leading to 'blasting off' effects
50-60%
Ketamine response rate for treatment-resistant depression Based on current clinical trial data, though early studies reported higher rates
2 days to 1 week
Duration of ketamine's antidepressant effect Can sometimes extend to two weeks, but highly variable
24 hours
Synaptic plasticity peak post-ketamine The window for increased brain plasticity starts around 4 hours and peaks at 24 hours after ketamine administration
86%
Alcohol addiction trial abstinence rate (ketamine + therapy) Observed at six months post-treatment in Celia Morgan's study
68%
Alcohol addiction trial abstinence rate (education control) Observed at six months post-treatment in Celia Morgan's study, highlighting non-specific effects
11 hours
Total therapy hours in alcohol addiction trial Delivered across seven sessions, sandwiching three ketamine infusions
96 patients
Patients in alcohol addiction trial (Phase 2) Divided into four arms, 24 patients per arm
Approximately 10 mmHg
Blood pressure increase during ketamine infusion Systolic/diastolic increase, though highly variable
Over 180 mmHg
Blood pressure exclusion threshold for ketamine treatment Systolic blood pressure, due to ketamine's effect on blood pressure